P&T Portfolio: Raptiva

Article

Raptiva for treatment of adult patients (18 years or older) with chronic, moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy

Recent Videos
1 expert is featured in this series.
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.